Echocardiography and Peak Endocardial Acceleration (PEA) Measurements in Cardiac Resynchronization Therapy (CRT)

This study has been completed.
Sponsor:
Information provided by:
Sorin Group
ClinicalTrials.gov Identifier:
NCT01066078
First received: February 9, 2010
Last updated: March 4, 2010
Last verified: March 2010

February 9, 2010
March 4, 2010
October 2007
October 2009   (final data collection date for primary outcome measure)
The timings of mitral (tMC) and aortic (tAC) valves closure by echocardiography and sonR [ Time Frame: 12 months ] [ Designated as safety issue: No ]
The timings of mitral (tMC) and aortic (tAC) valves closure by echocardiography and sonR [ Time Frame: Routine follow up ] [ Designated as safety issue: No ]
Complete list of historical versions of study NCT01066078 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Echocardiography and Peak Endocardial Acceleration (PEA) Measurements in Cardiac Resynchronization Therapy (CRT)
Echocardiography and PEA Measurements in CRT Therapy

This study used an external endocardial acceleration sensor (sonR sensor), placed on the patient's chest, to time the closure of aortic and mitral valves, and compared its performance with echocardiography.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample

CRT recipients

Congestive Heart Failure
Other: Echocardiography and SonR recording
CRT recipients
Intervention: Other: Echocardiography and SonR recording
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
216
October 2009
October 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Every patient coming in the participating centers for an echocardiographic exam and implanted with a pacemaker or an implantable cardioverter defibrillator (ICD) can be included in the study.

Exclusion Criteria:

  • Inability to understand the patient information sheet.
  • Minor patient or pregnant woman.
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
France
 
NCT01066078
RGEA01 - CAP PEA, RGEA01
No
Erwan DONAL, CCP, CHU Pontchaillou 35033 RENNES France
Sorin Group
Not Provided
Principal Investigator: Erwan DONAL, MD CHU Rennes
Sorin Group
March 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP